Clinical Trial Update: The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM) [Phase 4]

View source ↗

Summary

Phase 4 update describing the effects of fibrate therapy in two patients with neutral lipid storage disease with myopathy (NLSD-M).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutral Lipid Storage Disease with Myopathy

Drugs mentioned

• Fibrate therapy

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Neutral Lipid Storage Disease | Phase 4 | Status: COMPLETED